FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology and can be used in treating neovascular glaucoma. Avastin in dosage 1.25 mg is introduced into the anterior chamber. Said preparation is introduced simultaneously subconjunctivally in two opposite sectors 2.5 mg in each. Then 7-14 days later, counteropening fistulisation in two opposite sectors follows.
EFFECT: method allows reducing number of intra- and postoperative hemorrhagic complications, providing stable normalisation of intraocular pressure.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE TREATMENT OF NEOVASCULAR GLAUCOMA | 2022 |
|
RU2789438C1 |
| METHOD FOR TREATING PATIENTS FOR NEOVASCULAR GLAUCOMA | 2005 |
|
RU2290147C2 |
| METHOD FOR TREATING NEOVASCULAR GLAUCOMA | 2003 |
|
RU2244534C1 |
| METHOD FOR TREATING THE CASES OF NEOVASCULAR GLAUCOMA | 2003 |
|
RU2245123C1 |
| METHOD FOR COMBINED TREATMENT OF NEOVASCULAR GLAUCOMA ACCOMPANYING DIABETIC OR POSTTHROMBOTIC MACULAR EDEMA IN PATIENTS WITH RESIDUAL VISION | 2020 |
|
RU2726463C1 |
| METHOD FOR COMBINED TREATMENT OF SECONDARY NEOVASCULAR OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2786145C1 |
| METHOD FOR TREATING NEOVASCULAR GLAUCOMA CASES | 2005 |
|
RU2297813C1 |
| METHOD FOR COMBINED TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA | 2022 |
|
RU2786144C1 |
| METHOD FOR TREATING THE CASES OF NEOVASCULAR GLAUCOMA | 2005 |
|
RU2289374C1 |
| METHOD FOR TREATING THE CASES OF GLAUCOMA | 2002 |
|
RU2223075C2 |
